Randomized, open-label comparison of epoetin alfa extended dosing (80 000 U Q2W) vs weekly dosing (40 000 U QW) in patients with chemotherapy-induced anemia

Author： Henry David H.   Gordan Lucio N.   Charu Veena   Wilhelm Francois E.   Williams Denise   Xie John   Woodman Richard C.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.22, Iss.7, 2006-07, pp. : 1403-1413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized, controlled trial comparing darbepoetin alfa correction/maintenance dosing with weekly dosing for treating chemotherapy-induced anemia

By Kotasek Dusan   Canon Jean-Luc   Mateos Maria Victoria   Hedenus Michael   Rossi Greg   Taylor Kerry  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1387-1401

Informa Healthcare

Access to resources Recommend Favorite

A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy‐associated anemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 361-8609, Iss. 10, 2015-10 ,pp. : 877-881

John Wiley & Sons Inc

Access to resources Recommend Favorite

The cost-effectiveness of weekly epoetin alfa relative to weekly darbepoetin alfa in patients with chemotherapy-induced anemia

By Ben-Hamadi R.   Duh M. S.   Aggarwal J.   Henckler A.   Mckenzie R. S.   Tak Piech C.  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1677-1682

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy-induced anemia: the story of darbepoetin alfa

By Vansteenkiste Johan   Wauters Isabelle   Elliott Steven   Glaspy John   Hedenus Michael  

Current Medical Research and Opinion, Vol. 29, Iss. 4, 2013-04 ,pp. : 325-337

Informa Healthcare

Access to resources Recommend Favorite

The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease

By Cremieux Pierre-Yves   Van Audenrode Marc   Lefebvre Patrick  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2329-2336

Informa Healthcare

Access to resources Recommend Favorite